An article published in Experimental Biology and Medicine (Volume 242, Issue 7, March, 2017) describes a new drug delivery system for the treatment of cancer. The study, led by Dr. Horst A. von Recum from the Department of ...
Apr 20, 2017
0
1
Two years ago, former President Barack Obama announced the Precision Medicine initiative in his State of the Union Address. The initiative aspired to a "new era of medicine" where disease treatments could be specifically ...
Apr 19, 2017
0
1
Detailed analysis of two brain tumor subtypes has revealed that they may originate from the same type of neural progenitor cells and be distinguished by gene mutation patterns and by the composition of their microenvironments. ...
Mar 30, 2017
0
26
An article published in Experimental Biology and Medicine (Volume 242, Issue 6, March, 2017) identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department ...
Mar 30, 2017
0
7
The effects of a promising new approach to chemotherapy that involves frequent administration of dosage levels much lower than traditionally used appears to rely on the "normalization" of blood vessels within and around a ...
Feb 6, 2017
0
9
Cancer cells often delete genes that normally suppress tumor formation. These deletions also may extend to neighboring genes, an event known as "collateral lethality," which may create new options for development of therapies ...
Jan 18, 2017
0
7
Unprecedented images of cancer genome-mutating enzymes acting on DNA provide vital clues into how the enzymes work to promote tumor evolution and drive poor disease outcomes. These images, revealed by University of Minnesota ...
Dec 19, 2016
0
17
Massachusetts General Hospital (MGH) investigators have developed new methods for mapping and measuring solid stress - the force exerted by solid and elastic components - within tumors, an accomplishment that may lead to ...
Nov 28, 2016
0
0
Researchers describe the first evidence linking prolactin inducible protein (PIP) to the immune system's ability to recognize and destroy foreign cells, such as tumor cells. New research in PIP-deficient mice that demonstrates ...
Oct 28, 2016
0
0
Massachusetts General Hospital (MGH) investigators have identified a potential mechanism behind the resistance that inevitably develops to cancer treatment with a combination of chemotherapy and antiangiogenic drugs. In a ...
Oct 12, 2016
0
1
